Heather Stuart Shaw, MD

Assistant Professor of Medicine
Campus mail 508 Fulton St, C5020, Durham, NC 27705
Phone (919) 286-6941
Email address heather.shaw@duke.edu

Education and Training

  • Fellow in Hematology-Oncology, Medicine, Duke University, 1996 - 1999
  • Medical Resident, Medicine, Duke University, 1993 - 1996
  • M.D., Duke University, 1993

Publications

Anders, C. K., S. A. Snyder, R. C. Barrier, W. Demark-Wahnefried, R. A. Welch, P. K. Marcom, H. S. Shaw, S. Y. Chui, and K. L. Blackwell. “Inhibin A and B as predictive markers for chemotherapy-induced premature ovarian failure (POF) among premenopausal women with early stage breast cancer (ESBC)..” In Breast Cancer Research and Treatment, 94:S47–S47. SPRINGER, 2005.

Scholars@Duke

Shaw, Heather S., Katherine B. Hobbs, David J. Kroll, and Victoria L. Seewaldt. “Delayed-type hypersensitivity reaction with iscador M given in combination with cytotoxic chemotherapy..” J Clin Oncol 22, no. 21 (November 1, 2004): 4432–34. https://doi.org/10.1200/JCO.2004.04.140.

PMID
15514390
Full Text

Shaw, H. S., and D. J. Kroll. “The convergence of herb pharmacodynamics and herb-drug interactions on hemostasis..” Altern Ther Health Med 7, no. 6 (November 2001): 46–47.

PMID
11712470
Scholars@Duke

Kroll, D. J., H. S. Shaw, M. E. Wall, and N. H. Oberlies. “Variability in St. John's wort formulations is an important consideration..” Altern Ther Health Med 7, no. 6 (November 2001): 21–22.

PMID
11712467
Scholars@Duke

Liu, K., J. Marshall, H. S. Shaw, R. K. Dodge, and L. J. Layfield. “Effects of chemotherapy and tamoxifen on cervical and vaginal smears in bone marrow transplant recipients..” Acta Cytol 43, no. 6 (November 1999): 1027–33. https://doi.org/10.1159/000331349.

PMID
10578974
Full Text

Maxwell, G. L., J. I. Risinger, H. Shaw, A. Alvarez, J. C. Barrett, P. A. Futreal, and A. Berchuck. “Mutations in the PTEN tumor suppressor gene in cervical carcinomas.” International Journal of Gynecological Cancer 8, no. 6 (December 1, 1998): 489–93. https://doi.org/10.1046/j.1525-1438.1998.98102.x.

Full Text

Maxwell, G. L., J. I. Risinger, B. Tong, H. Shaw, J. C. Barrett, A. Berchuck, and P. A. Futreal. “Mutation of the PTEN tumor suppressor gene is not a feature of ovarian cancers..” Gynecol Oncol 70, no. 1 (July 1998): 13–16. https://doi.org/10.1006/gyno.1998.5039.

PMID
9698466
Full Text

Maxwell, G. L., J. I. Risinger, C. Gumbs, H. Shaw, R. C. Bentley, J. C. Barrett, A. Berchuck, and P. A. Futreal. “Mutation of the PTEN tumor suppressor gene in endometrial hyperplasias..” Cancer Res 58, no. 12 (June 15, 1998): 2500–2503.

PMID
9635567
Scholars@Duke

Pages